Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various...

To be presented at the 19th Annual Meeting of the International Society of Geriatric Oncology, Geneva, Nov 14-17, by Drs Howard W Bruckner et al & Dr Robert De Jager et al, both for the MZB...

Axon Enterprise, Inc. (Nasdaq: AAXN), the global leader in connected public safety technologies, today announced that Jawad Ahsan, Axon Chief Financial Officer (CFO), will be a featured speaker at...

Today, Dispel announced winning the Smart Utility Vendor to Watch award at the 2019 Smart Utility Summit hosted by AGORA. Voted on by an audience of over 150 North American electric, water, and...

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Joseph G. Oliveto, President and Chief Executive Officer, will present at the following investor conferences: The Jefferies 2019...